Dendritic Cell News and Research

Latest Dendritic Cell News and Research

ImmunoCellular Therapeutics seeks FDA orphan drug status for ICT-107 dendritic-cell based vaccine for GBM

ImmunoCellular Therapeutics seeks FDA orphan drug status for ICT-107 dendritic-cell based vaccine for GBM

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

2010 Aggregate Spend and Disclosure Reporting Industry Survey of compliance program experts

2010 Aggregate Spend and Disclosure Reporting Industry Survey of compliance program experts

ImmunoCellular Therapeutics, UPENN sign research agreement

ImmunoCellular Therapeutics, UPENN sign research agreement

Celldex Therapeutics presents CDX-1127 antibody program at AACR Annual Meeting

Celldex Therapeutics presents CDX-1127 antibody program at AACR Annual Meeting

Encouraging early data from Bellicum Pharmaceuticals' Phase I/II study of BPX-101 for mCRPC

Encouraging early data from Bellicum Pharmaceuticals' Phase I/II study of BPX-101 for mCRPC

Scientists grow cultured neurons to investigate basic mechanisms of memory

Scientists grow cultured neurons to investigate basic mechanisms of memory

Cegedim Dendrite announces global SaaS CRM agreement with UCB

Cegedim Dendrite announces global SaaS CRM agreement with UCB

MaxCyte, Medinet agree to amend License, Development and Supply Agreement

MaxCyte, Medinet agree to amend License, Development and Supply Agreement

ImmunoCellular Therapeutics files Annual Report with Securities and Exchange Commission for 2009

ImmunoCellular Therapeutics files Annual Report with Securities and Exchange Commission for 2009

Cegedim Dendrite signs five-year framework agreement with Pierre Fabre Laboratories

Cegedim Dendrite signs five-year framework agreement with Pierre Fabre Laboratories

Role Tregs play in therapeutic HIV vaccines

Role Tregs play in therapeutic HIV vaccines

Data on Argos Therapeutics' Phase 2a AGS-004 immunotherapy trial presented at Banff HIV Vaccines meeting

Data on Argos Therapeutics' Phase 2a AGS-004 immunotherapy trial presented at Banff HIV Vaccines meeting

Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

Cegedim Dendrite's Sample Management Solutions launched in Europe CE

Cegedim Dendrite's Sample Management Solutions launched in Europe CE

ImmunoCellular Therapeutics receives Notice of Allowance covering antibodies targeting pancreatic cancer

ImmunoCellular Therapeutics receives Notice of Allowance covering antibodies targeting pancreatic cancer

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

ImmunoCellular Therapeutics' dendritic cell-based vaccination with CSCs demonstrates survival benefits

ImmunoCellular Therapeutics' dendritic cell-based vaccination with CSCs demonstrates survival benefits

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

New anti-tumour vaccine for mesothelioma shows promising results

New anti-tumour vaccine for mesothelioma shows promising results

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.